This page addresses questions related to the Ars Pro and Ars Pro ++ subscriber offerings. Please consult the information below before contacting support. The Ars subscriber program launched in ...

Although ARS Pharmaceuticals’ approval for its epinephrine nasal spray came later than expected, the company ultimately received a thumbs up from the FDA in August and is now moving fast to expand ...

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

ARS Pharmaceuticals shares jumped Monday after the company inked a deal to commercialize its allergic reaction nasal spray internationally.

The Argentine Peso (ARS) exchange rates represented on this ... top 5 best UK travel money rates, historical exchange rates and historical charts.

Information provided on Forbes Advisor is for educational purposes only. Your financial situation is unique and the products and services we review may not be right for your circumstances.

While the trading rally has now paused, analysts predict that bitcoin's value will only continue rising following Trump's win ...

Wanna see a trick? Give us any topic and we can tie it back to the economy. At Planet Money, we explore the forces that shape our lives and bring you along for the ride. Don't just understand the ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak ...

Danny Crawford (R) of the Alabama House of Representatives, said to Ars Technica. "Cell-cultured meat products are so new that there's not really a framework for how state and federal labeling will ...

News site Ars Technica reports that Trump promises to start undoing the Biden administration’s progress on regulating AI ...

A little show about big ideas. From the people who make Planet Money, The Indicator helps you make sense of what's happening today. It's a quick hit of insight into work, business, the economy ...